fundvisualizer.com

Invesco Value Opportunities AVVOAX

Performance (before sales charge)

As of 12/31/2022

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 11/30/2022
Stock
81.16%
Non-U.S. Stock
14.80%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
4.03%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 11/30/2022

Basic materials

10.32%

Consumer cyclical

5.88%

Financial services

10.27%

Real estate

0.00%

Consumer defensive

4.30%

Health care

14.04%

Utilities

4.22%

Communication services

0.00%

Energy

18.05%

Industrials

20.63%

Technology

8.25%

Top 10 holdings

As of 11/30/2022

AECOM
3.35%
Horizon Therapeutics PLC
2.95%
Univar Solutions Inc
2.74%
APA Corp
2.65%
KBR Inc
2.64%
Flex Ltd
2.59%
Universal Health Services Inc Class B
2.55%
Centene Corp
2.50%
Huntington Bancshares Inc
2.49%
Webster Financial Corp
2.34%
Fund assets

$1.21 Billion

Share class

A

Morningstar category

Mid-Cap Value

Expense ratio

1.22%

Investment objective

Growth and Income

Documents